These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33341445)

  • 1. Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting.
    Brok J; Mavinkurve-Groothuis AMC; Drost J; Perotti D; Geller JI; Walz AL; Geoerger B; Pasqualini C; Verschuur A; Polanco A; Jones KP; van den Heuvel-Eibrink M; Graf N; Spreafico F
    Eur J Cancer; 2021 Feb; 144():113-122. PubMed ID: 33341445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.
    Vujanić GM; Gessler M; Ooms AHAG; Collini P; Coulomb-l'Hermine A; D'Hooghe E; de Krijger RR; Perotti D; Pritchard-Jones K; Vokuhl C; van den Heuvel-Eibrink MM; Graf N;
    Nat Rev Urol; 2018 Nov; 15(11):693-701. PubMed ID: 30310143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
    Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group.
    Jackson TJ; Brisse HJ; Pritchard-Jones K; Nakata K; Morosi C; Oue T; Irtan S; Vujanic G; van den Heuvel-Eibrink MM; Graf N; Chowdhury T;
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29702. PubMed ID: 35587187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
    Mavinkurve-Groothuis AM; van den Heuvel-Eibrink MM; Tytgat GA; van Tinteren H; Vujanic G; Pritchard-Jones KL; Howell L; Graf N; Bergeron C; Acha T; Catania S; Spreafico F
    Pediatr Blood Cancer; 2015 Apr; 62(4):598-602. PubMed ID: 25546733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapeutic Management of Wilms Tumor: An Update.
    Oostveen RM; Pritchard-Jones K
    Paediatr Drugs; 2019 Feb; 21(1):1-13. PubMed ID: 30604241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
    van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
    Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
    Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
    Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms' tumour. Optimal treatment strategies.
    Suryanarayan K; Marina N
    Drugs; 1998 Oct; 56(4):598-605. PubMed ID: 9806106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-tumor genetic heterogeneity in Wilms tumor samples.
    de Sá Pereira BM; Azevedo RM; Aguirre Neto JC; Menezes CF; Rodrigues KE; Faria PA; Camargo B; Maschietto M
    Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1496-1501. PubMed ID: 31994632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
    ; van den Heuvel-Eibrink MM; Pritchard-Jones K; van Tinteren H; Graf N
    Eur J Cancer; 2015 May; 51(8):995-6. PubMed ID: 25840668
    [No Abstract]   [Full Text] [Related]  

  • 12. Dataset for the reporting of nephrectomy specimens for Wilms' tumour treated with preoperative chemotherapy: recommendations from the International Society of Paediatric Oncology Renal Tumour Study Group.
    Vujanić GM; D'Hooghe E; Vokuhl C; Collini P
    Histopathology; 2021 Nov; 79(5):678-686. PubMed ID: 33942359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms tumour: prognostic factors, staging, therapy and late effects.
    Kaste SC; Dome JS; Babyn PS; Graf NM; Grundy P; Godzinski J; Levitt GA; Jenkinson H
    Pediatr Radiol; 2008 Jan; 38(1):2-17. PubMed ID: 18026723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and treatment of renal tumours in childhood.
    Brok J; Treger TD; Gooskens SL; van den Heuvel-Eibrink MM; Pritchard-Jones K
    Eur J Cancer; 2016 Nov; 68():179-195. PubMed ID: 27969569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
    van den Heuvel-Eibrink MM; Hol JA; Pritchard-Jones K; van Tinteren H; Furtwängler R; Verschuur AC; Vujanic GM; Leuschner I; Brok J; Rübe C; Smets AM; Janssens GO; Godzinski J; Ramírez-Villar GL; de Camargo B; Segers H; Collini P; Gessler M; Bergeron C; Spreafico F; Graf N;
    Nat Rev Urol; 2017 Dec; 14(12):743-752. PubMed ID: 29089605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents?
    Brok J; Pritchard-Jones K; Geller JI; Spreafico F
    Eur J Cancer; 2017 Jul; 79():205-213. PubMed ID: 28521171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumor.
    Pater L; Melchior P; Rübe C; Cooper BT; McAleer MF; Kalapurakal JA; Paulino AC
    Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28257. PubMed ID: 32893998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences.
    Vujanić GM; Parsons LN; D'Hooghe E; Treece AL; Collini P; Perlman EJ
    Histopathology; 2022 Jun; 80(7):1026-1037. PubMed ID: 35275409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers to detect Wilms tumors in pediatric patients: where are we now?
    Charlton J; Pavasovic V; Pritchard-Jones K
    Future Oncol; 2015; 11(15):2221-34. PubMed ID: 26235184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
    Morris L; Squire R; Sznajder B; van Tinteren H; Godzinski J; Powis M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27930. PubMed ID: 31339231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.